A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).
Epistemonikos ID: a18859fd3183670bc6e3988a9b62c817596dd863
First added on: May 13, 2024